IT201900002155A1 - Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici - Google Patents

Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici

Info

Publication number
IT201900002155A1
IT201900002155A1 IT102019000002155A IT201900002155A IT201900002155A1 IT 201900002155 A1 IT201900002155 A1 IT 201900002155A1 IT 102019000002155 A IT102019000002155 A IT 102019000002155A IT 201900002155 A IT201900002155 A IT 201900002155A IT 201900002155 A1 IT201900002155 A1 IT 201900002155A1
Authority
IT
Italy
Prior art keywords
serpinb3
therapeutic agents
genetically modified
modified cells
extracellular vesicles
Prior art date
Application number
IT102019000002155A
Other languages
English (en)
Inventor
Patrizia Pontisso
Maurizio Muraca
Alessandra Biasiolo
Santina Quarta
Mariagrazia Ruvoletto
Gianmarco Villano
Original Assignee
Univ Degli Studi Padova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Padova filed Critical Univ Degli Studi Padova
Priority to IT102019000002155A priority Critical patent/IT201900002155A1/it
Priority to EP20709715.5A priority patent/EP3923961A1/en
Priority to PCT/IB2020/051244 priority patent/WO2020165851A1/en
Priority to US17/430,739 priority patent/US20220143098A1/en
Publication of IT201900002155A1 publication Critical patent/IT201900002155A1/it

Links

IT102019000002155A 2019-02-14 2019-02-14 Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici IT201900002155A1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT102019000002155A IT201900002155A1 (it) 2019-02-14 2019-02-14 Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici
EP20709715.5A EP3923961A1 (en) 2019-02-14 2020-02-14 Extracellular vesicles isolated from genetically modified cells over-expressing serpinb3 for use in medicine
PCT/IB2020/051244 WO2020165851A1 (en) 2019-02-14 2020-02-14 Extracellular vesicles isolated from genetically modified cells over-expressing serpinb3 for use in medicine
US17/430,739 US20220143098A1 (en) 2019-02-14 2020-02-14 Extracellular vsicles isolated from genetically modified cells over-expressing serpinb3 for use in medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000002155A IT201900002155A1 (it) 2019-02-14 2019-02-14 Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici

Publications (1)

Publication Number Publication Date
IT201900002155A1 true IT201900002155A1 (it) 2020-08-14

Family

ID=66589717

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102019000002155A IT201900002155A1 (it) 2019-02-14 2019-02-14 Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici

Country Status (4)

Country Link
US (1) US20220143098A1 (it)
EP (1) EP3923961A1 (it)
IT (1) IT201900002155A1 (it)
WO (1) WO2020165851A1 (it)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014013258A1 (en) * 2012-07-19 2014-01-23 Reneuron Limited Stem cell microparticles
US20180220642A1 (en) * 2015-07-29 2018-08-09 Indiana University Research And Technology Corporation Materials and methods for treating and evaluating ischemic and/or reperfusion-injured tissue and/or tissue susceptible to same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017097854A1 (en) * 2015-12-08 2017-06-15 Umc Utrecht Holding B.V. Extracellular vesicle markers for stable angina and unstable angina

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014013258A1 (en) * 2012-07-19 2014-01-23 Reneuron Limited Stem cell microparticles
US20180220642A1 (en) * 2015-07-29 2018-08-09 Indiana University Research And Technology Corporation Materials and methods for treating and evaluating ischemic and/or reperfusion-injured tissue and/or tissue susceptible to same

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
CANNITO STURATO CPATERNOSTRO CBIASIOLO ACOLOMBATTO SCAMBIERI THEFOURTH SVILLANO GFASOLATO SMUSSO T: "Hypoxya up-regola SerpinB3 through HIF-2a in human liver cancer cells", ONCOTARGET, vol. 6, 2015, pages 2206 - 2221
FOURTH SVIDALINO LTURATO CRUVOLETTO MCALABRESE FVALENT MCANNITO SFASSINA GWORD MGATTA A: "SerpinB3 induces epithelial-mesenchymal transition", J PATHOL, vol. 221, 2010, pages 343 - 356
G, TURATOVILLANO CFOURTH SRUVOLETTO MCISCATO FPATERNOSTRO CWORD MSEMERARO RALVARO DBERNARDI P: "Hepatic progenitor cells overexpress SerpinB3", BMC CELL BIOL, 2014
HALL JUSTIN ET AL: "Delivery of Therapeutic Proteins via Extracellular Vesicles: Review and Potential Treatments for Parkinson's Disease, Glioma, and Schwannoma", CELLULAR AND MOLECULAR NEUROBIOLOGY, SPRINGER NEW YORK, US, vol. 36, no. 3, 26 March 2016 (2016-03-26), pages 417 - 427, XP035904161, ISSN: 0272-4340, [retrieved on 20160326], DOI: 10.1007/S10571-015-0309-0 *
JOSEPH M CATANZARO ET AL: "SerpinB3/B4: Mediators of Ras-driven inflammation and oncogenesis", CELL CYCLE, vol. 13, no. 20, 15 October 2014 (2014-10-15), US, pages 3155 - 3156, XP055629521, ISSN: 1538-4101, DOI: 10.4161/15384101.2014.969991 *
KOUREMBANAS S: "Exosomes: Vehicles of Intercellular Signaling, Biomarkers, and vectors of Cell Therapy", ANNU REV PHYSIOL, vol. 77, 2015, pages 13 - 27
MURACA MSMALL MFRANZIN CPTOLEMY AMJURGA MM, POZZOBON PERILONGO G: "diverging Concepts and Novel Perspectives in Regenerative Medicine", INT. J. MOL. SCI., vol. 18, no. 5, 2017, pages 1021
RUENN CHAI LAI ET AL: "Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome", INTERNATIONAL JOURNAL OF PROTEOMICS, vol. 91, no. 7, 1 January 2012 (2012-01-01), pages 2573 - 14, XP055155534, ISSN: 2090-2166, DOI: 10.1155/2012/971907 *
SCIACOVELLI CISCATO F, G, MVILLANO TURATO CBERNARDI PRASOLA APONTISSO P: "SerpinB3 protects from oidative damage by chemotherapeutics through inhibition of mithocondrial respratory complex I", ONCOTARGET, vol. 5, 2014, pages 2418 - 2427
TURATO CCANNITO SIMONATO S, G, DTERRIN LFOURTH SBIASIOLO ARUVOLETTO MMARTINI AFASOLATO SZANUS GCILLO U: "SerpinB3 and Yap interplay increases Myc oncogenic activity", SKI REP, vol. 5, 2015, pages 17701
TURATO CKENT PSEBASTIANI GCANNITO STERRIN LBIASIOLO ASIMONATO DWORD MPANTOPOULOS KPONTISSO P: "SerpinB3 is overexpressed in the liver in presence of iron Overload", J INVEST MED, vol. 66, 2018, pages 32 - 38
VIAUD SC THERY PLOIXS, T, V TURSZ LAPIERRELANTZ ZITVOGEL, LN CHAPUT: "Dendritic cell-derived exosomes for cancer immunotherapy: what's next?", CANCER RES, vol. 70, 2010, pages 1281 - 1285, XP055108702, DOI: doi:10.1158/0008-5472.CAN-09-3276

Also Published As

Publication number Publication date
WO2020165851A1 (en) 2020-08-20
EP3923961A1 (en) 2021-12-22
US20220143098A1 (en) 2022-05-12

Similar Documents

Publication Publication Date Title
CO2021004966A2 (es) Inhibidores de la proteína tirosina fosfatasa
MA48765A (fr) Cyanopyrrolidines substituées par sulfonamide ayant une activité en tant qu'inhibiteurs de dub
IL284422A (en) Receptors enabling targeted co-stimulation for acquired cellular therapy
EP4009989A4 (en) THERAPEUTIC EXTRACELLULAR VESICLES
BR112015014502A2 (pt) composições para higiene oral contendo haletos de zinco-aminoácidos
EA201691327A1 (ru) Полиморфные формы (s)-2-(1-(9h-пурин-6-иламино)пропил)-5-фтор-3-фенилхиназолин-4(3h)-она
CL2015001279A1 (es) Compuestos derivados de piridina, inhibidores del transportador de uratos urat 1; composicion farmaceutica que los comprende; uso para el tratamiento o prevencion de enfermedades tales como gota, hiperuricemia, hipertensión, enfermedades renales, entre otras.
ITUA20161510A1 (it) Composizione per colorare la fibra cheratinica
TR201900274T4 (tr) Geliştirilmiş adenovirüs formülasyonları.
IT201900024580A1 (it) Vescicole extracellulari da microalghe
DK3743420T3 (da) Heterocyclylamino-substituerede triazoler som modulatorer af rho-associeret proteinkinase
IL305753A (en) Extracellular vesicles from stem cells
NI201700129A (es) Azabenzimidazoles y su uso como moduladores del receptor ampa.
MA53273A (fr) Vésicules extracellulaires pour inhalation
BRPI1013259B8 (pt) moduladores lxr
IL291690A (en) Extracellular vesicle assemblies
DK3782571T3 (da) Lasersystem til vævsterapi med flere stråler
EP3443126A4 (en) FABRIC PROFILING BY MULTIPLEXED IMMUNOHISTOCHEMICAL CONSECUTIVE COLORING
IT201700118597A1 (it) Composizione per colorare la fibra cheratinica
TR201901977T4 (tr) Cxcr3 reseptörü modülatörleri olarak (r)-2-metil-piperazin türevleri.
MX2020006586A (es) Metodos para potenciar la eliminacion de impurezas durante una cromatografia con proteina a.
GT201300250A (es) Derivados de 2-amino-3-(imidazol-2-il)-piridin-4-ona, preparación de los mismos y uso terapéutico de los mismos
GB201915855D0 (en) An extracellular vesicle
EP3850104A4 (en) EXTRACELLULAR VESICLES FOR TARGETED THERAPY AGAINST MYELOID SUPPRESSOR CELLS
IT201900002155A1 (it) Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici